NCT06724068|Completed
Diabetes, Insulin Resistance and Body Composition
The Correlation Between Diabetes, Insulin Resistance and Body Composition
Loading search results
The Correlation Between Diabetes, Insulin Resistance and Body Composition
Sponsor study identifier
observational
515
1 country
1
Study Start
December 17, 2021
Actual (reported)Primary Completion
August 31, 2022
Actual (reported)Study Completion
August 31, 2022
Actual (reported)The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions. The main question\[s\] it aims to answer are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 31, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 17, 2021
Actual (reported)August 31, 2022
Actual (reported)August 31, 2022
Actual (reported)December 3, 2024
Actual (reported)December 9, 2024
Actual (reported)Prevalence of Sarcopenia in Diabetic Patients
The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2
Retrospective analysis of data collected between2019 and 2022
This retrospective study uses medical records and diagnostic data from patients with type 2 diabetes and healthy controls obtained from Qianfoshan Hospital from2019 to 2022
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
This study includes adult patients aged 18 years and older who were diagnosed with type 2 diabetes mellitus. The population consists of individuals with documented medical records, including diabetes duration, glycemic control data (HbA1c levels), and body composition measurements such as muscle mass assessments. The study also includes a control group of non-diabetic individuals matched by age and sex to enable comparative analysis.
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, 250000, China
Song Xuan, Doctor
Shandong First Medical University
515 participants (actual enrollment reported by the registry).
First Submitted
December 3, 2024
First Posted
December 9, 2024
Study Start
December 17, 2021
Actual (reported)Topical Insulin for Postoperative Wound Healing
Contact the study team to confirm eligibility.
Primary Completion
August 31, 2022
Actual (reported)Study Completion
August 31, 2022
Actual (reported)Last Updated
December 12, 2024
Record last verified: 2024-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: